Visunex Medical Systems is a pioneer in developing the most advanced technology and information systems for preserving the vision of patients around the world.
PanoCam LT represents the first entry in a novel imaging technology platform, combined with information systems engineered to help preserve healthy vision for every patient. The PanoCam Pro with its leading-edge technology, is the most comprehensive tool to aid in the diagnosis and management of ocular vision disorders. Our products maximize quality and efficiency in the flow of ocular images and patient data worldwide to all allied healthcare professionals whose joint mission is to preserve healthy vision.
Wei Su, Ph.D.
Chief Executive Officer
Dr. Wei Su has over 18 years of experience in medical device and healthcare industries. Prior to Visunex, Dr. Su served as the Co-founder, CTO and VP of Engineering at Clarity Medical Systems Inc. Dr. Su is also the CTO of Visunex Medical, and he is an innovator who has led the Visunex team to grow from a small team to over 70 people within two years. Dr. Su will focus on researching and developing ophthalmic wide-field imaging systems.
Sr. Vice President Corporate Development (Consultant)
Experienced executive and senior manager with 38 years in medical device sales, marketing, strategy and produt development. Before joining Visunex, Mr. Kealey held executive positions at Optovue Inc., as Sr. VP of Product Development & Business Strategy and VP of Sales & Marketing. Joining the company prior to market launch in 2006, he built the company’s domestic and international sales distribution channels, marketing and product management departments as well as developing its long-term business and marketing strategy. Prior to Optovue, Paul held positions as Vice President of Marketing for Clarity Medical Systems, Inc., Director of Marketing at Curon Medical. He also held senior management positions for companies including Carl Zeiss Meditec, Kowa Optimed and POP Medical Consulting Group.
To contact us, please use the following form.